• WNT5a/GSK3/β-catenin Axis Regulates Muscle FAP Adipogenesis

  2026-04-28

  This study uncovers the WNT5a/GSK3/β-catenin signaling axis as a central regulator of adipogenesis in skeletal muscle fibro/adipogenic progenitors (FAPs). These findings provide mechanistic insight with implications for muscle regeneration, myopathies, and targeted pathway inhibition strategies.

• GPR35-KLF5 Circuitry Decodes Damage Signals for Mucosal Repa

  2026-04-28

  This study identifies a tryptophan metabolism–dependent gatekeeping mechanism, wherein GPR35 detects colonic mucosal damage and activates KLF5-mediated repair programs. The findings clarify how intestinal epithelial cells translate metabolic cues into coordinated responses, offering new mechanistic insight and therapeutic targets for ulcerative colitis.

• PBS Liposomes: Precision Controls for In Vivo Macrophage Res

  2026-04-27

  Explore how PBS Liposomes serve as advanced, inert controls in macrophage depletion studies. This article delves into their mechanism, scientific rationale, and unique value for in vivo experimental integrity using phosphate-buffered saline liposomes.

• M1 Macrophage Exosomes Drive Enteric Neuronal Injury via MMP

  2026-04-27

  This study uncovers a mechanistic link between M1 macrophage-derived exosomal MMP8 and enteric neuronal apoptosis through TGF-β pathway activation, providing new insight into the neuroimmune basis of gastrointestinal motility disorders. The findings suggest that targeting MMP8 may offer a therapeutic approach for restoring intestinal function in such disorders.

• Sodium Orthovanadate: Precision Phosphorylation State Preser

  2026-04-26

  Sodium Orthovanadate (Na3VO4) is the gold-standard reagent for preserving protein tyrosyl phosphorylation in kinase-driven signaling and metabolic assays. This article delivers actionable protocols, troubleshooting strategies, and translational insights that maximize reproducibility and signal fidelity in complex cell signaling workflows.

• Caspase 3/7 Drive Cytoprotective Autophagy in Breast Cancer

  2026-04-25

  This study uncovers a conserved, non-apoptotic role for caspase 3 and caspase 7 in promoting cytoprotective autophagy and mediating DNA damage response under non-lethal stress in human breast cancer cells. The findings suggest new therapeutic avenues by linking effector caspase activity to stress adaptation and genomic stability.

• Dorsomorphin (Compound C): Precision Tools for Metabolic and

  2026-04-24

  Explore the advanced use of Dorsomorphin (Compound C) as a selective AMPK and BMP pathway inhibitor. This article uniquely focuses on practical assay optimization, protocol decisions, and real-world differentiation for researchers working with metabolic and autophagic pathways.

• Neurotensin: Advancing GPCR Trafficking & miRNA Research

  2026-04-24

  This thought-leadership article bridges cutting-edge mechanistic insights into Neurotensin’s role as a Neurotensin receptor 1 activator with actionable strategies for translational researchers. We examine how careful experimental design—leveraging precision reagents like APExBIO Neurotensin (CAS 39379-15-2)—enables robust GPCR trafficking mechanism studies and miRNA regulation in gastrointestinal cells, overcoming key analytical challenges such as spectral interference. By synthesizing recent advances in fluorescence-based detection and miRNA signaling, we chart a vision for interference-free, high-fidelity translational workflows that directly address unmet needs in gastrointestinal and neurobiological research.

• Leucovorin Calcium: Advancing Translational Assembloid Oncol

  2026-04-23

  This thought-leadership article explores the mechanistic and strategic dimensions of Leucovorin Calcium (calcium folinate) in contemporary translational oncology, spotlighting its role in overcoming methotrexate-induced growth suppression and advancing complex assembloid model research. By integrating recent evidence from patient-derived gastric cancer assembloid studies, the article provides actionable guidance for translational scientists aiming to optimize cell viability, decode drug resistance, and accelerate the development of personalized cancer therapies.

• Tacalcitol Monohydrate: Synthetic Vitamin D3 in Applied Rese

  2026-04-23

  Tacalcitol monohydrate, a synthetic analog of vitamin D3, bridges advanced dermatology and oncology workflows with robust NGF induction and synergistic anticancer effects. Discover stepwise experimental setups, troubleshooting, and actionable protocol parameters for maximizing data quality and reproducibility with this low-toxicity vitamin D analog.

• VDR Activation Inhibits Ferroptosis in Cisplatin-Induced AKI

  2026-04-22

  This study demonstrates that activating the vitamin D receptor (VDR) mitigates cisplatin-induced acute kidney injury (AKI) by suppressing ferroptosis, a regulated, iron-dependent cell death pathway. The findings reveal a mechanistic link between VDR signaling, the antioxidant enzyme GPX4, and the inhibition of ferroptosis, offering new insights for therapeutic strategies in AKI.

• Budesonide in Pulmonary Drug Permeability: Scientific Advanc

  2026-04-22

  Explore how Budesonide, a leading anti-inflammatory corticosteroid, enables next-generation pulmonary drug permeability assays. This article uniquely connects biomimetic chromatography insights with practical guidance for respiratory inflammation research.

• Novel Culture Paradigm Extends Mouse Corneal Epithelial Prol

  2026-04-21

  An X et al. present a feeder-free, serum-free 6C medium containing small-molecule modulators—including IWP-2—enabling prolonged proliferation and maintenance of mouse corneal epithelial cells (mCEC) in vitro and in vivo. This approach advances corneal regenerative research by suppressing epithelial-mesenchymal transdifferentiation and improving the harvest of progenitor cells for transplantation applications.

• MCC950 Sodium in Endothelial Pyroptosis: Precision Tools for

  2026-04-21

  Explore the advanced application of MCC950 sodium in dissecting pyroptosis and vascular inflammation, with a focus on endothelial cell dysfunction in atherosclerosis. This article uniquely integrates mechanistic insights, protocol guidance, and translational value for inflammatory disease research.

• Methotrexate: Folate Antagonist Mechanisms & Research Protoc

  2026-04-20

  Methotrexate is a folate antagonist that inhibits dihydrofolate reductase (DHFR), blocking DNA synthesis and cell proliferation. It is widely used as an immunosuppressive and anti-inflammatory agent in research. Robust evidence supports its utility in apoptosis induction and permeability profiling.

15647 records 1/1044 page Next 12345 下5页 Last page